Radiomics features as predictors to distinguish fast and slow progression of Mild Cognitive Impairment to Alzheimer's disease

Prediction of Alzheimer's disease (AD) from Mild Cognitive Impairment (MCI) by analyzing Magnetic Resonance Imaging (MRI) image features has become popular in recent years. However, defining effective predictive biomarkers is still challengeable. The 'radiomics' is an established method to identify advanced and high order quantitative imaging features for computer-aided diagnosis and has been applied into oncology study. However, it has not been applied into brain disorder disease study. Therefore, the purpose of this study is to identify whether the features from radiomics could be the predictors of the conversion from MCI to AD. We analyzed 197 samples with MRI scans from the ADNI database, which contained 32 healthy subjects and 165 MCI patients. Firstly, we extracted 215 radiomics features from hippocampus. Then we used Cronbach's alpha coefficient, the intra-class correlation coefficient, Kaplan-Meier model and cox regression to select 44 radiomics features as effective features. Finally, we used SVM classification to validate these features. The results showed that the classification accuracy using linear, polynomial and sigmoid kernel could achieve 80.0%, 93.3% and 86.6% to distinguish MCI-to-AD fast and slow converter. As a result, this study indicated that the radiomics features are potential to be applied into predicting AD from MCI.

[1]  Zhuangzhi Yan,et al.  Differences in Aβ brain networks in Alzheimer's disease and healthy controls , 2017, Brain Research.

[2]  Paul Kinahan,et al.  Radiomics: Images Are More than Pictures, They Are Data , 2015, Radiology.

[3]  D. Rueckert,et al.  Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI , 2012, Neurobiology of Aging.

[4]  M. Weiner,et al.  Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia , 2005, Annals of neurology.

[5]  Michael Wagner,et al.  Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia , 2017, Alzheimer's Research & Therapy.

[6]  I. El Naqa,et al.  A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities , 2015, Physics in medicine and biology.

[7]  D. Oldridge,et al.  MRI features predict survival and molecular markers in diffuse lower-grade gliomas , 2017, Neuro-oncology.

[8]  Nick C Fox,et al.  The clinical use of structural MRI in Alzheimer disease , 2010, Nature Reviews Neurology.

[9]  Andre Dekker,et al.  Radiomics: the process and the challenges. , 2012, Magnetic resonance imaging.

[10]  Stephen F. Carter,et al.  Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease , 2013, Neurology.

[11]  Nicola Toschi,et al.  Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease. , 2013, The Medical clinics of North America.

[12]  M. Bobinski,et al.  The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease , 1999, Neuroscience.

[13]  R. Mayeux,et al.  Hippocampal and entorhinal atrophy in mild cognitive impairment , 2007, Neurology.

[14]  F. Turkheimer,et al.  A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities , 2015 .

[15]  P. Lambin,et al.  Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach , 2014, Nature Communications.

[16]  Zhuangzhi Yan,et al.  A novel individual-level morphological brain networks constructing method and its evaluation in PET and MR images , 2017, Heliyon.